LIPUSTOBART
UNII H6KN31H3XF

Substance Identification & Data

This profile provides standardized clinical and technical data for Lipustobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H6KN31H3XF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2639481-06-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
H6KN31H3XF
CAS Registry Number
2639481-06-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LIPUSTOBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C153149
National Cancer Institute reference terminology for clinical and research data.
INN ID
12392
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lipustobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LIPUSTOBART

Common Names & Synonyms

ANTI-PD-1 MONOCLONAL ANTIBODY LZM009
IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL LZM009 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LZM009 .KAPPA.-CHAIN, DIMER
LIPUSTOBART [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus